Literature DB >> 22929438

Statins and cerebral hemodynamics.

Sotirios Giannopoulos1, Aristeidis H Katsanos, Georgios Tsivgoulis, Randolph S Marshall.   

Abstract

HMG-CoA reductase inhibitors (statins) are associated with improved stroke outcome. This observation has been attributed in part to the palliative effect of statins on cerebral hemodynamics and cerebral autoregulation (CA), which are mediated mainly through the upregulation of endothelium nitric oxide synthase (eNOS). Several animal studies indicate that statin pretreatment enhances cerebral blood flow after ischemic stroke, although this finding is not further supported in clinical settings. Cerebral vasomotor reactivity, however, is significantly improved after long-term statin administration in most patients with severe small vessel disease, aneurysmal subarachnoid hemorrhage, or impaired baseline CA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22929438      PMCID: PMC3494001          DOI: 10.1038/jcbfm.2012.122

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  36 in total

1.  Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage.

Authors:  Matthew J McGirt; John R Lynch; Augusto Parra; Huaxin Sheng; Robert D Pearlstein; Daniel T Laskowitz; Dale A Pelligrino; David S Warner
Journal:  Stroke       Date:  2002-12       Impact factor: 7.914

2.  Influence of atorvastatin treatment on L-arginine cerebrovascular reactivity and flow-mediated dilatation in patients with lacunar infarctions.

Authors:  Janja Pretnar-Oblak; Miso Sabovic; Miran Sebestjen; Tomaz Pogacnik; Marjan Zaletel
Journal:  Stroke       Date:  2006-08-24       Impact factor: 7.914

3.  Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia.

Authors:  Minoru Asahi; Zhihong Huang; Sunu Thomas; Shin-ichi Yoshimura; Toshihisa Sumii; Tatsuro Mori; Jianhua Qiu; Sepideh Amin-Hanjani; Paul L Huang; James K Liao; Eng H Lo; Michael A Moskowitz
Journal:  J Cereb Blood Flow Metab       Date:  2005-06       Impact factor: 6.200

4.  Transfer function analysis of dynamic cerebral autoregulation in humans.

Authors:  R Zhang; J H Zuckerman; C A Giller; B D Levine
Journal:  Am J Physiol       Date:  1998-01

5.  Lack of effect of pravastatin on cerebral blood flow or parenchymal volume loss in elderly at risk for vascular disease.

Authors:  V Hester ten Dam; Frieke M A Box; Anton J M de Craen; Dominique M J van den Heuvel; Edward L E M Bollen; Heather M Murray; Mark A van Buchem; Rudi G J Westendorp; Gerard Jan Blauw
Journal:  Stroke       Date:  2005-08       Impact factor: 7.914

6.  Atorvastatin therapy is associated with greater and faster cerebral hemodynamic response.

Authors:  Guofan Xu; Michele E Fitzgerald; Zhifei Wen; Sean B Fain; David C Alsop; Timothy Carroll; Michele L Ries; Howard A Rowley; Mark A Sager; Sanjay Asthana; Sterling C Johnson; Cynthia M Carlsson
Journal:  Brain Imaging Behav       Date:  2008-06-01       Impact factor: 3.978

7.  Effects of initiation and acute withdrawal of statins on the neurovascular coupling mechanism in healthy, normocholesterolemic humans.

Authors:  Bernhard Rosengarten; Dieter Auch; Manfred Kaps
Journal:  Stroke       Date:  2007-10-25       Impact factor: 7.914

8.  Effects of short term atorvastatin treatment on cerebral hemodynamics in CADASIL.

Authors:  Nils Peters; Tobias Freilinger; Christian Opherk; Thomas Pfefferkorn; Martin Dichgans
Journal:  J Neurol Sci       Date:  2007-05-24       Impact factor: 3.181

9.  Monitoring of cerebral vasodilatory capacity with transcranial Doppler carbon dioxide inhalation in patients with severe carotid artery disease.

Authors:  Randolph S Marshall; Tanja Rundek; Douglas M Sproule; Brian-Fred M Fitzsimmons; Shauna Schwartz; Ronald M Lazar
Journal:  Stroke       Date:  2003-03-06       Impact factor: 7.914

10.  Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial.

Authors:  Ming-Yuan Tseng; Marek Czosnyka; Hugh Richards; John D Pickard; Peter J Kirkpatrick
Journal:  Stroke       Date:  2005-08       Impact factor: 7.914

View more
  26 in total

1.  Statin pretreatment is associated with better outcomes in large artery atherosclerotic stroke.

Authors:  Georgios Tsivgoulis; Aristeidis H Katsanos; Vijay K Sharma; Christos Krogias; Robert Mikulik; Konstantinos Vadikolias; Milija Mijajlovic; Apostolos Safouris; Christina Zompola; Simon Faissner; Viktor Weiss; Sotirios Giannopoulos; Spyros Vasdekis; Efstathios Boviatsis; Anne W Alexandrov; Konstantinos Voumvourakis; Andrei V Alexandrov
Journal:  Neurology       Date:  2016-02-24       Impact factor: 9.910

2.  Evaluating the Risk of Macrovascular Events and Mortality Among People With Multiple Sclerosis in England.

Authors:  Raffaele Palladino; Ruth Ann Marrie; Azeem Majeed; Jeremy Chataway
Journal:  JAMA Neurol       Date:  2020-07-01       Impact factor: 18.302

3.  Lipid Control and Beyond: Current and Future Indications for Statin Therapy in Stroke.

Authors:  Shadi Yaghi; Mitchell S V Elkind
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-04

4.  Perihematoma cerebral blood flow is unaffected by statin use in acute intracerebral hemorrhage patients.

Authors:  Laura C Gioia; Mahesh Kate; Rebecca McCourt; Bronwen Gould; Shelagh B Coutts; Dariush Dowlatshahi; Negar Asdaghi; Thomas Jeerakathil; Michael D Hill; Andrew M Demchuk; Brian Buck; Derek Emery; Ashfaq Shuaib; Kenneth Butcher
Journal:  J Cereb Blood Flow Metab       Date:  2015-03-11       Impact factor: 6.200

5.  Mitochondrial Complex I Reversible S-Nitrosation Improves Bioenergetics and Is Protective in Parkinson's Disease.

Authors:  Chiara Milanese; Victor Tapias; Sylvia Gabriels; Silvia Cerri; Giovanna Levandis; Fabio Blandini; Maria Tresini; Sruti Shiva; John Timothy Greenamyre; Mark T Gladwin; Pier G Mastroberardino
Journal:  Antioxid Redox Signal       Date:  2017-09-21       Impact factor: 8.401

Review 6.  Statin Adherence and the Risk of Stroke: A Dose-Response Meta-Analysis.

Authors:  Tao Xu; Xinyuan Yu; Shu Ou; Xi Liu; Jinxian Yuan; Yangmei Chen
Journal:  CNS Drugs       Date:  2017-04       Impact factor: 5.749

Review 7.  Emerging therapies in traumatic brain injury.

Authors:  Patrick M Kochanek; Travis C Jackson; Nikki Miller Ferguson; Shaun W Carlson; Dennis W Simon; Erik C Brockman; Jing Ji; Hülya Bayır; Samuel M Poloyac; Amy K Wagner; Anthony E Kline; Philip E Empey; Robert S B Clark; Edwin K Jackson; C Edward Dixon
Journal:  Semin Neurol       Date:  2015-02-25       Impact factor: 3.420

8.  Neurovascular regulation in the ischemic brain.

Authors:  Katherine Jackman; Costantino Iadecola
Journal:  Antioxid Redox Signal       Date:  2015-01-10       Impact factor: 8.401

9.  Early treatment with atorvastatin exerts parenchymal and vascular protective effects in experimental cerebral ischaemia.

Authors:  C Potey; T Ouk; O Petrault; M Petrault; V Berezowski; J Salleron; R Bordet; S Gautier
Journal:  Br J Pharmacol       Date:  2015-10-06       Impact factor: 8.739

10.  Randomized Evaluation of Carotid Occlusion and Neurocognition (RECON) trial: main results.

Authors:  Randolph S Marshall; Joanne R Festa; Ying-Kuen Cheung; Marykay A Pavol; Colin P Derdeyn; William R Clarke; Tom O Videen; Robert L Grubb; Kevin Slane; William J Powers; Ronald M Lazar
Journal:  Neurology       Date:  2014-01-29       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.